SCHEMBL8765103

SCHEMBL8765103

CCc1ccc(-c2c(C(F)F)nn(-c3ccc(CC)cc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.54
PTGS1 P23219 12/20 0.54
CA2 P00918 5/20 0.47
CA1 P00915 4/20 0.45
CA4 P22748 3/20 0.45
CA9 Q16790 3/20 0.45
PDPK1 O15530 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
ATM Q13315 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8765284 0.96 PTGS2 (0.51) PTGS2PTGS1CA2CA1CA9
SCHEMBL8764505 0.95 PTGS2 (0.49) PTGS2PTGS1CA2CA1CA4
SCHEMBL8765087 0.90 PTGS2 (0.43) PTGS2PTGS1
SCHEMBL8765285 0.87 PTGS2 (0.60) PTGS2PTGS1CA2CA1CA4
SCHEMBL8764457 0.86 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL8765925 0.86 PTGS2 (0.51) PTGS2PTGS1CA2CA1CA9
SCHEMBL8765747 0.86 PTGS2 (0.60) PTGS2PTGS1CA2CA1CA4
SCHEMBL8765209 0.86 PTGS2 (0.43) PTGS2PTGS1
SCHEMBL8766233 0.85 PTGS2 (0.52) PTGS2PTGS1CA2CA1
SCHEMBL8764362 0.85 PTGS2 (0.48) PTGS2PTGS1CA2CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed